BioPlus Co. Ltd. (099430) is a leading biotechnology company based in South Korea. The company specializes in the research, development, and production of bioengineered products, primarily focusing on pharmaceuticals and industrial biotechnology. BioPlus's portfolio includes a wide range of therapeutic proteins and monoclonal antibodies, addressing various medical conditions. The company's commitment to innovation and scientific excellence has positioned it as a key player in the global biotech industry, with a strong focus on bringing life-changing treatments to market.

BioPlus Co. Ltd. (099430) Stock Analysis, Discussion Forum and Financial Metrics - KRX Exchange

099430's latest dividend is 70 KRW on December 27, 2023

099430 Stock Discussion Forum and Message Board

News for KRX: 099430